Enrollment has begun in the first feasibility study looking at the effectiveness of MR guided Focused Ultrasound to treat essential tremor.
The study will examine 15 patients that underwent non-invasive treatment using InSightec Ltd’s ExAblate Nuero at University of Virginia in Charleston.
The use of MR Focused Ultrasound (MRgFUS) has gained widespread attention lately as a means chronic neuropathic pain, targeted drug delivery and sonosthrombolysis, which are described in the current issue of The Journal of Neurosurgery.
Essential tremor affects basic movements. A third of all patients do not respond to drug therapy and typically consider surgery, which carries a set of risks. MR Focused Ultrasound is viewed as possible non-invasive treatment with tremendous potential.
InSightec has reportedly spent roughly $150 million to develop a device for clinical application, according to a press release.